blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2590660

EP2590660 - THERAPEUTIC USE OF NEURAL STEM CELLS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.08.2020
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  20.09.2019
FormerGrant of patent is intended
Status updated on  27.05.2019
FormerExamination is in progress
Status updated on  19.05.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Reneuron Limited
10 Nugent Road Surrey Research Park Guildford
Surrey GU2 7AF / GB
[2013/20]
Inventor(s)01 / CORTELING, Randolph
ReNeuron Limited
10 Nugent Road
Surrey Research Park
Guildford, Surrey GU2 7AF / GB
02 / HICKS, Caroline
ReNeuron Limited
10 Nugent Road
Surrey Research Park
Guildford, Surrey GU2 7AF / GB
03 / SINDEN, John
ReNeuron Limited
10 Nugent Road
Surrey Research Park
Guildford, Surrey GU2 7AF / GB
04 / PRICE, Jack
Centre for the Cellular Basis of Behaviour
Kings College London
Institute of Psychiatry
125 Coldharbour Lane
London, Greater London SE5 9NU / GB
 [2013/20]
Representative(s)Gill Jennings & Every LLP
The Broadgate Tower
20 Primrose Street
London EC2A 2ES / GB
[2019/43]
Former [2013/20]Jappy, John William Graham
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
London EC2A 2ES / GB
Application number, filing date11738783.711.07.2011
[2019/43]
WO2011GB51289
Priority number, dateGB2010001158909.07.2010         Original published format: GB 201011589
[2013/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012004611
Date:12.01.2012
Language:EN
[2012/02]
Type: A1 Application with search report 
No.:EP2590660
Date:15.05.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 12.01.2012 takes the place of the publication of the European patent application.
[2013/20]
Type: B1 Patent specification 
No.:EP2590660
Date:23.10.2019
Language:EN
[2019/43]
Search report(s)International search report - published on:EP12.01.2012
ClassificationIPC:A61K35/30, C12N5/0797, G01N33/50
[2013/20]
CPC:
A61K35/30 (EP,US); A61P25/00 (EP); A61P25/18 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P37/06 (EP);
C12N5/0623 (EP,US); A61K2035/122 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/20]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:THERAPEUTISCHE VERWENDUNG VON NEURALEN STAMMZELLEN[2019/23]
English:THERAPEUTIC USE OF NEURAL STEM CELLS[2013/20]
French:USAGE THERAPUETIQUE DES CELLULES SOUCHES NEURALES[2019/23]
Former [2013/20]THERAPEUTISCHE VERWENDUNG VON NERVENSTAMMZELLEN
Former [2013/20]UTILISATION THÉRAPEUTIQUE DE CELLULES SOUCHES NEURALES
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase12.12.2012National basic fee paid 
12.12.2012Designation fee(s) paid 
12.12.2012Examination fee paid 
Examination procedure09.05.2012Request for preliminary examination filed
International Preliminary Examining Authority: EP
12.12.2012Examination requested  [2013/20]
09.10.2015Despatch of a communication from the examining division (Time limit: M04)
29.10.2015Reply to a communication from the examining division
10.05.2017Despatch of a communication from the examining division (Time limit: M06)
20.11.2017Reply to a communication from the examining division
02.08.2018Despatch of a communication from the examining division (Time limit: M04)
19.11.2018Reply to a communication from the examining division
28.05.2019Communication of intention to grant the patent
16.09.2019Fee for grant paid
16.09.2019Fee for publishing/printing paid
16.09.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.10.2015
Opposition(s)24.07.2020No opposition filed within time limit [2020/40]
Fees paidRenewal fee
10.07.2013Renewal fee patent year 03
14.07.2014Renewal fee patent year 04
10.07.2015Renewal fee patent year 05
13.09.2016Renewal fee patent year 06
12.07.2017Renewal fee patent year 07
11.07.2018Renewal fee patent year 08
15.07.2019Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
31.07.201606   M06   Fee paid on   13.09.2016
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.07.2011
AL23.10.2019
AT23.10.2019
CY23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
MK23.10.2019
MT23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
TR23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
IE11.07.2020
LU11.07.2020
[2022/32]
Former [2022/27]HU11.07.2011
AL23.10.2019
AT23.10.2019
CY23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
MT23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
TR23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
IE11.07.2020
LU11.07.2020
Former [2022/26]AL23.10.2019
AT23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
TR23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
IE11.07.2020
LU11.07.2020
Former [2021/37]AL23.10.2019
AT23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
IE11.07.2020
LU11.07.2020
Former [2021/20]AL23.10.2019
AT23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
LU11.07.2020
Former [2021/15]AL23.10.2019
AT23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/51]AL23.10.2019
AT23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/38]AL23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SK23.10.2019
SM23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/37]AL23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SK23.10.2019
SM23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/36]AL23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/35]AL23.10.2019
CZ23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS24.02.2020
PT24.02.2020
Former [2020/32]AL23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RS23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS24.02.2020
PT24.02.2020
Former [2020/25]ES23.10.2019
FI23.10.2019
HR23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RS23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS24.02.2020
PT24.02.2020
Former [2020/24]ES23.10.2019
FI23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS24.02.2020
PT24.02.2020
Former [2020/23]ES23.10.2019
FI23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
PT24.02.2020
Former [2020/22]FI23.10.2019
LT23.10.2019
NL23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
PT24.02.2020
Former [2020/21]NL23.10.2019
NO23.01.2020
Former [2020/20]NL23.10.2019
Cited inInternational search[XDAY]EP1645626  (RENEURON LTD [GB]) [XD] 1,7 * the whole document * [A] 5,6 [Y] 2-4;
    [XDAY] - STROEMER PAUL ET AL, "The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion", NEUROREHABILITATION AND NEURAL REPAIR,, (20091101), vol. 23, no. 9, ISSN 1552-6844, pages 895 - 909, XP009152608 [XD] 1,7 * page 901 - page 902 * * page 907 - page 908 * [A] 5,6 [Y] 2-4
 [XAY]  - THOMAS R J ET AL, "Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line", BIOTECHNOLOGY LETTERS, SPRINGER NETHERLANDS, DORDRECHT, (20090403), vol. 31, no. 8, doi:10.1007/S10529-009-9989-1, ISSN 1573-6776, pages 1167 - 1172, XP019727659 [X] 1,7 * the whole document * [A] 5,6 [Y] 2-4

DOI:   http://dx.doi.org/10.1007/s10529-009-9989-1
 [XAY]  - POLLOCK K ET AL, "A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke", EXPERIMENTAL NEUROLOGY, ACADEMIC PRESS, NEW YORK, NY, US, vol. 199, no. 1, doi:10.1016/J.EXPNEUROL.2005.12.011, ISSN 0014-4886, (20060501), pages 143 - 155, (20060501), XP024946020 [X] 1,7 * the whole document * [A] 5,6 [Y] 2-4

DOI:   http://dx.doi.org/10.1016/j.expneurol.2005.12.011
 [Y]  - PARK DONG-HYUK ET AL, "Increased neuronal proliferation in the dentate gyrus of aged rats following neural stem cell implantation.", STEM CELLS AND DEVELOPMENT FEB 2010 LNKD- PUBMED:19569872, (201002), vol. 19, no. 2, ISSN 1557-8534, pages 175 - 180, XP009152757 [Y] 1-4,7 * page 177 - page 179 *
 [YDP]  - M TFILIN ET AL, "Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior", MOLECULAR PSYCHIATRY, (20101201), vol. 15, no. 12, doi:10.1038/mp.2009.110, ISSN 1359-4184, pages 1164 - 1175, XP055008273 [YDP] 2-4 * published online 27.10.2009*; page 1164 - page 1169 *

DOI:   http://dx.doi.org/10.1038/mp.2009.110
 [Y]  - GERD KEMPERMANN ET AL, "Depressed new Neurons?-Adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression", BIOLOGICAL PSYCHIATRY, (20030901), vol. 54, no. 5, doi:10.1016/S0006-3223(03)00319-6, ISSN 0006-3223, pages 499 - 503, XP055008622 [Y] 1-4,7 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0006-3223(03)00319-6
 [YDA]  - KIM Y K ET AL, "Cytokine imbalance in the pathophysiology of major depressive disorder", PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, OXFORD, GB, vol. 31, no. 5, doi:10.1016/J.PNPBP.2007.03.004, ISSN 0278-5846, (20070630), pages 1044 - 1053, (20070528), XP025320539 [YD] 1-4,7 * the whole document * [A] 5,6

DOI:   http://dx.doi.org/10.1016/j.pnpbp.2007.03.004
 [YDA]  - ELLER ET AL, "Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder", PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, OXFORD, GB, (20080202), vol. 32, no. 2, doi:10.1016/J.PNPBP.2007.09.015, ISSN 0278-5846, pages 445 - 450, XP022452772 [YD] 1-4,7 * the whole document * [A] 5,6

DOI:   http://dx.doi.org/10.1016/j.pnpbp.2007.09.015
 [YA]  - MCAFOOSE J ET AL, "Evidence for a cytokine model of cognitive function", NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, PERGAMON PRESS LTD, XX, vol. 33, no. 3, doi:10.1016/J.NEUBIOREV.2008.10.005, ISSN 0149-7634, (20090301), pages 355 - 366, (20081018), XP025913464 [Y] 1-4,7 * page 363 - page 364 * [A] 5,6

DOI:   http://dx.doi.org/10.1016/j.neubiorev.2008.10.005
 [XP]  - ONO T ET AL, "The role of neural stem cells for in vitro models of schizophrenia: Neuroprotection via Akt/ERK signal regulation", SCHIZOPHRENIA RESEARCH, ELSEVIER, NETHERLANDS, vol. 122, no. 1-3, doi:10.1016/J.SCHRES.2010.05.008, ISSN 0920-9964, (20100901), pages 239 - 247, (20100830), XP027249737 [XP] 1-4,7 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.schres.2010.05.008
ExaminationWO2009096445
 EP2239320
by applicantEP1645626
    - LOPEZ AD, MURRAY CC, "The Global Burden of disease", NAT MED, (1998), vol. 4, no. 11, pages 1241 - 3
    - GUMNICK JF, NEMEROFF CB, "Problems with currently available antidepressants", J CLIN PSYCHIATRY, (2000), vol. 61, no. 10, pages 5 - 15
    - WONG ML, LICINIO J, "Research and treatment approaches to depression", NATURE REVIEWS NEUROSCIENCE, (2001), vol. 2, doi:doi:10.1038/35072566, pages 343 - 351, XP009161506

DOI:   http://dx.doi.org/10.1038/35072566
    - CASPI A, SUGDEN K, MOFFITT TE, TAYLOR A, CRAIG IW, HARRINGTON H, MCCLAY J, MILL J, MARTIN J, BRAITHWAITE A, "Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene", SCIENCE, (2003), vol. 301, pages 386 - 389
    - HEUSER I, "The hypothalamic-pituitary-adrenal system in depression", PHARMACOPSYCHIATRY, (1998), vol. 31, pages 10 - 13
    - YOUNG EA, HASKETT RF, MURPHY-WEINBURG V, WATSON SJ, AKIL H, "Loss of glucocorticoid fast feedback in depression", ARCH GEN PSYCHIATRY, (1991), vol. 48, pages 693 - 699
    - SHELINE YI, WANY P, GADO MH, CSERNANSKY JG, VANNIER MW, "Hippocampal atrophy in recurrent major depression", PROC NATL ACAD SCI USA, (1996), vol. 93, pages 3908 - 3913
    - SAPOLSKY RM, "Glucocorticoids and atrophy of the human hippocampus", SCIENCE, (1996), vol. 273, pages 749 - 775
    - WATANABE Y, GOULD E, MCEWEN BS, "Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurones", BRAIN RES, (1982), vol. 588, doi:doi:10.1016/0006-8993(92)91597-8, pages 341 - 345, XP024277558

DOI:   http://dx.doi.org/10.1016/0006-8993(92)91597-8
    - SAPOLSKY RM, KREY LC, MCEWEN BS, "Prolonged glucocorticoid exposure reduces hippocampal neurone number: implications for aging", J NEUROSCI, (1985), vol. 5, pages 1222 - 1227
    - UNO H, TARARA R, ELSE JG, SULEMAN MA, SAPOLSKY RM, "Hippocampal damage associated with prolonged and fatal death in primates", J NEUROSCI, (1998), vol. 9, pages 1705 - 1711
    - SAPOLSKY RM, "Glucocorticoids, hippocampus, and the glutamatergic synapse", PROG BRAIN RES, (1990), vol. 86, pages 13 - 23
    - WOOLEY CS, GOULD E, MCEWEN BS, "Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurones", BRAIN RES, (1990), vol. 531, doi:doi:10.1016/0006-8993(90)90778-A, pages 225 - 231, XP024267167

DOI:   http://dx.doi.org/10.1016/0006-8993(90)90778-A
    - STEIN-BEHERENS B, MATTSON MP, CHANG , YEH M, SAPOLSKY R, "Stress exacerbates neurone loss and cytoskeletal pathology in the hippocampus", J NEUROSCI, (1994), vol. 14, pages 5373 - 5380
    - MARGARINOS AM, MCEWEN BS, FLUGGE G, FUCHS E, "Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurones in subordinate tree shrews", J NEUROSCI, (1996), vol. 16, pages 3534 - 3540
    - ELKIS H, FRIEDMAN L, WISE A, MELTZER HY, "Meta-analysis of studies of ventricular enlargement and cortical sulcal prominence in mood disorders", ARCH GEN PSYCHIATRY, (1995), vol. 52, pages 735 - 746
    - SCHIEPERS OJ, WICHERS MC, MAES M, "Cytokines and major depression", PROG NEUROPSYCOPHARMACOL BIOL PSYCHIATRY, (2005), vol. 29, no. 2, doi:doi:10.1016/j.pnpbp.2004.11.003, pages 201 - 217, XP025311094

DOI:   http://dx.doi.org/10.1016/j.pnpbp.2004.11.003
    - DUNN AJ, SWIERGIEL AH, DE BEAUREPAIRE R, "Cytokines as mediators of depression:what can we learn from animal studies", NEUROSCI BIOBEH REV, (2005), vol. 29, doi:doi:10.1016/j.neubiorev.2005.03.023, pages 891 - 909, XP004912821

DOI:   http://dx.doi.org/10.1016/j.neubiorev.2005.03.023
    - KIM YK, NA KS, SHIN KH, JUNG HY, CHOI SH, KIM JB, "Cytokine imbalance in the pathophysiology of major depressive disorder", PROG NEUROPSYCOPHARMACOL BIOL PSYCHIATRY, (2007), vol. 31, no. 5, doi:doi:10.1016/j.pnpbp.2007.03.004, pages 1044 - 1053, XP025320539

DOI:   http://dx.doi.org/10.1016/j.pnpbp.2007.03.004
    - BRAMBILLA F, MONTELEONE P, MAJ M, "Interleukin-1 beta and tumor necrosis factor alpha in children with major depressive disorder or dysthymia", J AFFECT DISORD, (2004), vol. 78, pages 273 - 277
    - KONUK N, TEKIN 10, OZTURK U, ATIK L, ATASOY N, BEKTAS S, ERDOGAN A, "Plasma levels of tumor necrosis factor-alpha and Interleukin-6 in obsessive compulsive disorder", MEDIATORS INFLAMM, (2007), page 65704
    - GOSHEN 1, YIRMIYA R, "Interleukin-1 (IL-1): A central regulator of stress responses", FRONT NEUROENDOCRINOL, (2009), vol. 30, doi:doi:10.1016/j.yfrne.2008.10.001, pages 30 - 45, XP025846383

DOI:   http://dx.doi.org/10.1016/j.yfrne.2008.10.001
    - KOO JW, DUMAN RS, "L-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress", PROC NATL ACAD SCI USA, (2008), vol. 105, no. 2, pages 751 - 6
    - BEN MENACHEM-ZIDON O, GOSHEN , KRIESLE T, BEN MENACHEM Y, REINHARTZ E, BEN HUR T, YIRMIYA R, "Intrahippocampal transplantation of transgenic Neural precursor cells overexpressing Interleukin 1 receptor antagonist blocks chronic isolation induced impairment in memory and neurogenesis", NEUROPSYCHOPHARMACOL, (2008), vol. 33, pages 2251 - 2262
    - SLUZEWSKA A, RYBAKOWSKI J, BOSMANS E, SOBIESKA M, BERGHMANS R, MAES M, WIKTOROWICZ K, "Indicators of immune activation in major depressive illness", PSYCHIATRY RES, (1996), vol. 64, pages 161 - 167
    - BASTERZI AD, AYDEMIR C, KISA C, AKSARAY S, TUZER V, YAZICI K, GOKA E, "IL-6 levels decrease with SSRI treatment in patients with major depression", HUM PSYCOPHARMACOL, (2005), vol. 20, pages 473 - 476
    - MALBERG JE, EISCH AJ, NESTLER EJ, DUMAN RS, "Chronic antidepressant treatment increases neurogenesis in the adult rat hippocampus", J NEUROSCI, (2000), vol. 20, no. 24, pages 9104 - 9110
    - MALBERG JE, DUMAN RS, "Cell proliferation in the adult hippocampus is decreased by inescapable stress: Reversal by Fluoxetine treatment", NEUROPSYCHOPHARMACOLOGY, (2003), vol. 28, pages 1562 - 1571
    - SAHAY A, HEN R, "Adult hippocampal neurogenesis in depression", NAT NEUROSCI, (2007), vol. 10, no. 9, pages 1110 - 1115
    - SANTARELLI L, SAXE M, GROSS C, SURGET A, BATTAGLIA F, DULAWA S, WEISSTAUB N, LEE J, DUMAN R, ARANCIO O, "Requirement of hippocampul neurogenesis for the behavioural effects of antidepressants", SCIENCE, (2003), vol. 3012, pages 805 - 809
    - O'BRIEN S, SCULLY P, FITZGERALD P, SCOTT LV, DINAN TG, "Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy", J PSYCHIATR RES, (2007), vol. 41, doi:doi:10.1016/j.jpsychires.2006.05.013, pages 326 - 331, XP005797984

DOI:   http://dx.doi.org/10.1016/j.jpsychires.2006.05.013
    - ELLER T, VASAR V, SHLIK J, MARON E, "Proinflammatory cytokines and treatment response to escitalopram in major depressive disorder", PROG NEUROPSYCHOPHARMACOL BIOL PSYCHIATRY, (2008), vol. 32, pages 445 - 450
    - HONG ZF, HUANG XJ, YIN ZY, ZHAO WX, WANG XM, "Immunosuppressive function of bone marrow mesenchymal stem cells on acute rejection of liver allografts in rats", TRANSPLANTATION PROCEEDINGS, (2009), vol. 41, doi:doi:10.1016/j.transproceed.2008.10.020, pages 403 - 409, XP026070937

DOI:   http://dx.doi.org/10.1016/j.transproceed.2008.10.020
    - LI Y, TREDGET EE, GHAFFARI A, LIN X, KILANI RT, GHAHARY A, "Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic substitute", JOURNAL INVEST DERMATOL, (2006), vol. 126, doi:doi:10.1038/sj.jid.5700022, pages 128 - 136, XP055324556

DOI:   http://dx.doi.org/10.1038/sj.jid.5700022
    - STROEMER P, PATEL S, HOPE A, OLIVEIRA C, POLLOCK K, SINDEN J, "The neural stem cell line CTXOE03 promotes behavioural recovery and endogenous neurogenesis after experimental stroke in a dose dependent fashion", NEUROREHABIL NEURAL REPAIR, (2009), vol. 23, no. 9, pages 895 - 909, XP009152608
    - PARK DH, EVE DJ, SANBERG PR, MUSSO J 3RD, BACHSTETTER AD, WOLFSON A, SCHLUNK A, BARADEZ MO, SINDEN JD, GEMMA C, "Increased neuronal proliferation in the dentate gyrus of aged rats following neural stem cell implantation", STEM CELLS DEV, (2010), vol. 19, no. 2, pages 175 - 180, XP009152757
    - COUILLARD-DEPRES S, WUERTINGER C, KANDASAMY M, CAIONI M, STADLER K, AIGNER R, BOGDAHN U, AIGNER L, "Ageing abolishes the effects of fluoxetine on neurogenesis", MOL PSYCHIATRY, (2009), vol. 14, no. 9, pages 856 - 864
    - TFILIN M, SUDAI E, MERENLENDER A, GISPAN I, YADID G, TURGEMAN, "Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behaviour", MOLECULAR PSYCHIATRY, (2009), pages 1 - 12
    - STAHL SM, NIERENBURG AA, GORMAN JM, "Evidence of early onset of antidepressant effect in randomized controlled trials", J CLIN PSYCHIATRY, (2001), vol. 62, no. 4, pages 17 - 23
    - ERESHEFSKY L, ALFARO CL, LAM YWF, "Treating depression: potential drug interactions", PSYCH ANN, (1997), vol. 27, pages 244 - 258
    - FINK F, "Convulsive therapy: a review of the first 55 years", J AFFECT DISORD, (2001), vol. 63, no. 1-3, pages 1 - 15
    - ZETTERSTROM TSC, PEI Q, GRAHAME-SMITH DG, "Repeated electric convulsive shock extends the duration of enhanced expression of BDNF in rat brain compared with a single administration", MOL BRAIN RES, (1998), vol. 57, pages 106 - 110
    - SKOLNICK P, LEGUTKO B, LI X, BYMASTER FP, "Current perspectives on the development of non-biogenic amine-based antidepressants", PHARMACOLOGICAL RESEARCH, (2001), vol. 43, no. 5, pages 411 - 422
    - "Monoamine oxidase inhibitors", HIMMELHOCH JM, Comprehensive Textbook of Psychiatry, WILLIAMS AND WILKINS, (1995), pages 2038 - 2054
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.